Neuroimaging and fluid biomarkers in Parkinson's disease in an era of targeted interventions
A Zarkali, GEC Thomas, H Zetterberg… - Nature …, 2024 - nature.com
A major challenge in Parkinson's disease is the variability in symptoms and rates of
progression, underpinned by heterogeneity of pathological processes. Biomarkers are …
progression, underpinned by heterogeneity of pathological processes. Biomarkers are …
Decoding the cellular trafficking of prion-like proteins in neurodegenerative diseases
C Hu, Y Yan, Y Jin, J Yang, Y Xi, Z Zhong - Neuroscience Bulletin, 2024 - Springer
The accumulation and spread of prion-like proteins is a key feature of neurodegenerative
diseases (NDs) such as Alzheimer's disease, Parkinson's disease, or Amyotrophic Lateral …
diseases (NDs) such as Alzheimer's disease, Parkinson's disease, or Amyotrophic Lateral …
Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease
F Nabizadeh, K Pirahesh, E Ramezannezhad - Neurological Sciences, 2023 - Springer
Background Previous studies investigated CSF levels of α-synuclein (α-syn), amyloid-β (Aβ1-
42), total tau (t-tau), and phosphorylated tau (p-tau) with clinical progression of Parkinson's …
42), total tau (t-tau), and phosphorylated tau (p-tau) with clinical progression of Parkinson's …
Systematic Review of Post-Traumatic Parkinsonism, an Emerging Parkinsonian Disorder Among Survivors of Traumatic Brain Injury
C Rojvirat, GR Arismendi, E Feinstein… - Neurotrauma …, 2024 - liebertpub.com
This systematic review focuses on an increasing subset of traumatic brain injury (TBI)
survivors who develop post-traumatic parkinsonism (PTP), characterized by slowness of …
survivors who develop post-traumatic parkinsonism (PTP), characterized by slowness of …